Early signs that using AI helps tumor boards improve workflows and care decisions.
Jeffrey T. Lenert, M.D., MBA, FACS, Associate Chief Medical Officer, Oncology & Genomics, IBM Watson Health
Advertisement
Articles by Jeffrey T. Lenert, M.D., MBA, FACS, Associate Chief Medical Officer, Oncology & Genomics, IBM Watson Health
Advertisement
Latest Updated Articles
The Role of AI with Tumor BoardsPublished: November 7th 2019 | Updated:
Advertisement
Advertisement
